Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Uric Acid and Cardiovascular Risk
Daniel I. Feig, Duk‐Hee Kang, Richard J. Johnson
New England Journal of Medicine (2008) Vol. 359, Iss. 17, pp. 1811-1821
Open Access | Times Cited: 2268

Showing 1-25 of 2268 citing articles:

The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
Bolormaa Vandanmagsar, Yun‐Hee Youm, Anthony Ravussin, et al.
Nature Medicine (2011) Vol. 17, Iss. 2, pp. 179-188
Open Access | Times Cited: 2382
2016 updated EULAR evidence-based recommendations for the management of gout
Pascal Richette, Michael Doherty, Eliseo Pascual, et al.
Annals of the Rheumatic Diseases (2016) Vol. 76, Iss. 1, pp. 29-42
Open Access | Times Cited: 1401
A laser-engraved wearable sensor for sensitive detection of uric acid and tyrosine in sweat
Yiran Yang, Yu Song, Xiangjie Bo, et al.
Nature Biotechnology (2019) Vol. 38, Iss. 2, pp. 217-224
Closed Access | Times Cited: 1000
American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for Management of Dyslipidemia and Prevention of Cardiovascular Disease
Paul S. Jellinger, Yehuda Handelsman, Paul D. Rosenblit, et al.
Endocrine Practice (2017) Vol. 23, pp. 1-87
Closed Access | Times Cited: 988
Glucose transporters in the 21st Century
Bernard Thorens, Mike Mueckler
AJP Endocrinology and Metabolism (2009) Vol. 298, Iss. 2, pp. E141-E145
Open Access | Times Cited: 936
The Tumor Lysis Syndrome
Scott C. Howard, Deborah P. Jones, Ching‐Hon Pui
New England Journal of Medicine (2011) Vol. 364, Iss. 19, pp. 1844-1854
Open Access | Times Cited: 910
Gout
Pascal Richette, Thomas Bardin
The Lancet (2009) Vol. 375, Iss. 9711, pp. 318-328
Closed Access | Times Cited: 842
Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular Risk
Marián Goicoechea, Soledad García de Vinuesa, Úrsula Verdalles, et al.
Clinical Journal of the American Society of Nephrology (2010) Vol. 5, Iss. 8, pp. 1388-1393
Open Access | Times Cited: 794
Uric acid transport and disease
Alexander So, Bernard Thorens
Journal of Clinical Investigation (2010) Vol. 120, Iss. 6, pp. 1791-1799
Open Access | Times Cited: 767
Hypertension in developing countries
M. Mohsen Ibrahim, Albertino Damasceno
The Lancet (2012) Vol. 380, Iss. 9841, pp. 611-619
Closed Access | Times Cited: 656
Hyperuricemia and coronary heart disease: A systematic review and meta‐analysis
Seoyoung C. Kim, James P. Guevara, Kyoung Mi Kim, et al.
Arthritis Care & Research (2010) Vol. 62, Iss. 2, pp. 170-180
Open Access | Times Cited: 651
How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial
Silvio E. Inzucchi, Bernard Zinman, David Fitchett, et al.
Diabetes Care (2017) Vol. 41, Iss. 2, pp. 356-363
Open Access | Times Cited: 640
Uric Acid Induces Hepatic Steatosis by Generation of Mitochondrial Oxidative Stress
Miguel A. Lanaspa, Laura Gabriela Sánchez‐Lozada, Yea-Jin Choi, et al.
Journal of Biological Chemistry (2012) Vol. 287, Iss. 48, pp. 40732-40744
Open Access | Times Cited: 619
Decreased extra-renal urate excretion is a common cause of hyperuricemia
Kimiyoshi Ichida, Hirotaka Matsuo, Tappei Takada, et al.
Nature Communications (2012) Vol. 3, Iss. 1
Open Access | Times Cited: 588
SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control
Martín Cowie, Miles Fisher
Nature Reviews Cardiology (2020) Vol. 17, Iss. 12, pp. 761-772
Closed Access | Times Cited: 583
Uric acid and chronic kidney disease: which is chasing which?
Richard J. Johnson, Takahiko Nakagawa, Diana Jalal, et al.
Nephrology Dialysis Transplantation (2013) Vol. 28, Iss. 9, pp. 2221-2228
Open Access | Times Cited: 581
Oxidative stress with an activation of the renin–angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction
Min-A Yu, Laura Gabriela Sánchez‐Lozada, Richard J. Johnson, et al.
Journal of Hypertension (2010) Vol. 28, Iss. 6, pp. 1234-1242
Closed Access | Times Cited: 575
Prevalence of Hyperuricemia and Gout in Mainland China from 2000 to 2014: A Systematic Review and Meta-Analysis
Rui Liu, Cheng Han, Di Wu, et al.
BioMed Research International (2015) Vol. 2015, pp. 1-12
Open Access | Times Cited: 561
Hypothesis: Could Excessive Fructose Intake and Uric Acid Cause Type 2 Diabetes?
Richard J. Johnson, Santos E. Perez-Pozo, Yuri Y. Sautin, et al.
Endocrine Reviews (2009) Vol. 30, Iss. 1, pp. 96-116
Open Access | Times Cited: 490
Renal, metabolic and cardiovascular considerations of SGLT2 inhibition
Ralph A. DeFronzo, Luke Norton, Muhammad Abdul‐Ghani
Nature Reviews Nephrology (2016) Vol. 13, Iss. 1, pp. 11-26
Closed Access | Times Cited: 477
Gout
Tuhina Neogi
New England Journal of Medicine (2011) Vol. 364, Iss. 5, pp. 443-452
Closed Access | Times Cited: 471
Hyperuricemia and risk of stroke: A systematic review and meta‐analysis
Seoyoung C. Kim, James P. Guevara, Kyoung Mi Kim, et al.
Arthritis Care & Research (2009) Vol. 61, Iss. 7, pp. 885-892
Open Access | Times Cited: 466
Effects of tempol and redox-cycling nitroxides in models of oxidative stress
Christopher S. Wilcox
Pharmacology & Therapeutics (2010) Vol. 126, Iss. 2, pp. 119-145
Open Access | Times Cited: 436
Hyperuricemia as a Mediator of the Proinflammatory Endocrine Imbalance in the Adipose Tissue in a Murine Model of the Metabolic Syndrome
William S. Baldwin, Steven McRae, George Marek, et al.
Diabetes (2011) Vol. 60, Iss. 4, pp. 1258-1269
Open Access | Times Cited: 414
Uric acid and cardiovascular disease
Gjin Ndrepepa
Clinica Chimica Acta (2018) Vol. 484, pp. 150-163
Closed Access | Times Cited: 404
Page 1 - Next Page

Scroll to top